SYRS
Syros Pharmaceuticals Inc.
Halal Rating :
Last Price
$0.22
Last updated:
Market Cap
-
7D Change
3.53%
1 Year Change
-96.8%
Company Overview
Industries
Exchange
Next Earnings Date
Syros Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases. The company uses its gene control platform to develop therapies that target the root cause of diseases. Their lead product candidates include tamibarotene for higher-risk myelodysplastic syndrome (HR-MDS) and SY-2101 for acute promyelocytic leukemia (APL).
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Syros Pharmaceuticals Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.